Agile Therapeutics AGRX reported its Q1 earnings results on Thursday, May 11, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Agile Therapeutics missed estimated earnings by 3.47%, reporting an EPS of $-7.76 versus an estimate of $-7.5.
Revenue was up $2.05 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $2.5 which was followed by a 9.33% drop in the share price the next day.
Here's a look at Agile Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -11.5 | -14.5 | -14.5 | -240 |
| EPS Actual | -9 | -11.5 | -135.5 | -189 |
| Revenue Estimate | 3.08M | 2.33M | 1.76M | 1.22M |
| Revenue Actual | 4.00M | 3.00M | 2.13M | 1.76M |
To track all earnings releases for Agile Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
